01/01/2023
Baltimore, Maryland
Healthcare & Prescribed drugs
JuneBrain, with a valuation of $8 million, is elevating funds on Republic. The corporate is empowering eye care and neurology communities with its distant illness monitoring options. JuneBrain is making developments in retinal imaging with its automated, high-performance, and clever system used for imaging and evaluation of retina construction and microvasculature. The corporate has been awarded $1.5 million in grants from the Nationwide Science Basis and generated income of $704,000 in 2022. Samantha Scott based JuneBrain in July 2019. The present crowdfunding marketing campaign has a minimal goal of $25,000 and a most goal of $1.24 million. The marketing campaign proceeds will likely be used for launching the {hardware} and software program, creating strategic partnerships, and advertising.
Abstract Revenue and Loss Assertion
|
Income |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
|
|
||
|
|
||
|
Web Revenue |
$139,921 |
$-96,495 |
Abstract Steadiness Sheet
|
Money |
$231,098 |
$13,225 |
|
Accounts Receivable |
$0 |
$0 |
|
Whole Belongings |
$231,098 |
$13,225 |
|
Quick-Time period Debt |
$39,422 |
$61,477 |
|
Lengthy-Time period Debt |
$150,000 |
$50,000 |
|
Whole Liabilities |
$189,422 |
$111,477 |
Financials as of: 12/30/2022



